LOGIN  |  REGISTER

CVS Health supporting customers, patients, members and colleagues amid California wildfires

January 10, 2025 | Last Trade: US$67.26 0.66 0.99

WOONSOCKET, R.I., Jan. 10, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) is actively supporting its customers, members, provider partners and colleagues as they respond to the California wildfires. The company prioritizes the health and safety of impacted communities and is dedicated to providing access to the products and services they need.

  • CVS Pharmacy stores are reopening as it is safe to do so. If a store has not yet reopened, the pharmacy's phone lines will be rerouted to a nearby open CVS Pharmacy to help patients access their prescriptions. Patients with a scheduled vaccination will be notified of any changes to their appointment by email or text message. Stores are also receiving additional supplies of essential and emergency items.
  • CVS Caremark®, the company's pharmacy benefit manager, is enabling pharmacy claims for one-time emergency refills of a 30-day supply of medication for plan members in impacted areas.
  • CVS Specialty® patients who are within the emergency area and are taking specialty medications will be contacted to discuss alternate delivery arrangements, if needed. CVS Specialty is actively reaching out to patients in emergency-affected areas who need to schedule or reschedule their orders. Order deliveries are being redirected to patients' temporary addresses as needed. Outreach efforts will continue to ensure all patients have access to the medications they require.
  • Aetna® clinical response teams have expanded their engagement with Medicare and Commercial members in potentially impacted areas to ensure member safety and access to emergency services.
  • Aetna members affected by these wildfires can also seek emergency care anywhere, as needed. Aetna will monitor the impact the wildfires have on its network doctors, hospitals and other health care providers and will modify its policies as necessary for providers and members to enable access to care. Providers and members can contact customer service with any questions.
  • Additionally, Aetna is expanding its Resources For Living (RFL) services to ensure individuals and organizations have access to care regardless of whether it is part of their existing benefits. Services include in-the-moment mental health phone support, a dedicated crisis support website and community resource information. Individuals and organizations who do not have RFL can call 1-833-327-AETNA, and those with RFL should contact their designated RFL number.
  • CVS Health is contacting colleagues who are in impacted areas to confirm they are safe and offer crisis support. Information about community resources and emotional support services is available through the company's employee assistance program.

CVS Health is also working with disaster relief organizations to provide on-the-ground support for local communities.

About CVS Health

CVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues — including more than 40,000 physicians, pharmacists, nurses and nurse practitioners. Wherever and whenever people need us, we help them with their health — whether that's managing chronic diseases, staying compliant with their medications or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system — and their personal health care — by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media. 

Media contact
Kara Page
401-302-9353
This email address is being protected from spambots. You need JavaScript enabled to view it.

Viking Therapeutics

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page